Amyloid-beta and tau protein beyond Alzheimer's disease

M Abyadeh, V Gupta, JA Paulo… - Neural Regeneration …, 2024 - journals.lww.com
The aggregation of amyloid-beta peptide and tau protein dysregulation are implicated to
play key roles in Alzheimer's disease pathogenesis and are considered the main …

Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments

P Maiti, J Manna, GL Dunbar - Translational neurodegeneration, 2017 - Springer
Gradual degeneration and loss of dopaminergic neurons in the substantia nigra, pars
compacta and subsequent reduction of dopamine levels in striatum are associated with …

Parkinson's disease age at onset genome‐wide association study: defining heritability, genetic loci, and α‐synuclein mechanisms

C Blauwendraat, K Heilbron, CL Vallerga… - Movement …, 2019 - Wiley Online Library
Background Increasing evidence supports an extensive and complex genetic contribution to
PD. Previous genome‐wide association studies (GWAS) have shed light on the genetic …

Classification of GBA1 Variants in Parkinson's Disease: The GBA1‐PD Browser

SC Parlar, FP Grenn, JJ Kim… - Movement …, 2023 - Wiley Online Library
Background GBA1 variants are among the most common genetic risk factors for Parkinson's
disease (PD). GBA1 variants can be classified into three categories based on their role in …

Genetics of Parkinson's disease

CM Lill - Molecular and cellular probes, 2016 - Elsevier
Almost two decades after the identification of SNCA as the first causative gene in
Parkinson's disease (PD) and the subsequent understanding that genetic factors play a …

Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's

G Liu, B Boot, JJ Locascio, IE Jansen… - Annals of …, 2016 - Wiley Online Library
Objective We hypothesized that specific mutations in the β‐glucocerebrosidase gene (GBA)
causing neuropathic Gaucher's disease (GD) in homozygotes lead to aggressive cognitive …

Association of GBA mutations and the E326K polymorphism with motor and cognitive progression in Parkinson disease

MY Davis, CO Johnson, JB Leverenz… - JAMA …, 2016 - jamanetwork.com
Importance Parkinson disease (PD) is heterogeneous in symptom manifestation and rate of
progression. Identifying factors that influence disease progression could provide …

Genetic risk of Parkinson disease and progression: an analysis of 13 longitudinal cohorts

H Iwaki, C Blauwendraat, HL Leonard, G Liu… - Neurology …, 2019 - neurology.org
Objective To determine if any association between previously identified alleles that confer
risk for Parkinson disease and variables measuring disease progression. Methods We …

A growth-factor-activated lysosomal K+ channel regulates Parkinson's pathology

J Wie, Z Liu, H Song, TF Tropea, L Yang, H Wang… - Nature, 2021 - nature.com
Lysosomes have fundamental physiological roles and have previously been implicated in
Parkinson's disease,,,–. However, how extracellular growth factors communicate with …

Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts

H Iwaki, C Blauwendraat, HL Leonard… - Movement …, 2019 - Wiley Online Library
Background Several reports have identified different patterns of Parkinson's disease
progression in individuals carrying missense variants in GBA or LRRK2 genes. The overall …